nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR1—pancreatic cancer	0.291	0.351	CbGaD
Pasireotide—SSTR3—pancreatic cancer	0.291	0.351	CbGaD
Pasireotide—SSTR2—pancreatic cancer	0.248	0.298	CbGaD
Pasireotide—Lipase increased—Sunitinib—pancreatic cancer	0.00214	0.0377	CcSEcCtD
Pasireotide—Lipase increased—Irinotecan—pancreatic cancer	0.00176	0.0311	CcSEcCtD
Pasireotide—Octreotide—SSTR1—pancreatic cancer	0.00148	0.257	CrCbGaD
Pasireotide—Octreotide—SSTR3—pancreatic cancer	0.00148	0.257	CrCbGaD
Pasireotide—Vapreotide—SSTR2—pancreatic cancer	0.00144	0.25	CrCbGaD
Pasireotide—Amylase increased—Sunitinib—pancreatic cancer	0.00132	0.0233	CcSEcCtD
Pasireotide—Octreotide—SSTR2—pancreatic cancer	0.00125	0.219	CrCbGaD
Pasireotide—Blood glucose increased—Sunitinib—pancreatic cancer	0.00123	0.0217	CcSEcCtD
Pasireotide—Electrocardiogram QT prolonged—Sunitinib—pancreatic cancer	0.00098	0.0173	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Tamoxifen—pancreatic cancer	0.000777	0.0137	CcSEcCtD
Pasireotide—Prothrombin level increased—Epirubicin—pancreatic cancer	0.000589	0.0104	CcSEcCtD
Pasireotide—Prothrombin level increased—Doxorubicin—pancreatic cancer	0.000545	0.0096	CcSEcCtD
Pasireotide—Injection site reaction—Gemcitabine—pancreatic cancer	0.000502	0.00884	CcSEcCtD
Pasireotide—Dry skin—Erlotinib—pancreatic cancer	0.000484	0.00852	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Tamoxifen—pancreatic cancer	0.00048	0.00846	CcSEcCtD
Pasireotide—Hypokalaemia—Erlotinib—pancreatic cancer	0.00048	0.00846	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Tamoxifen—pancreatic cancer	0.00047	0.00828	CcSEcCtD
Pasireotide—Hypoglycaemia—Sunitinib—pancreatic cancer	0.000468	0.00824	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Erlotinib—pancreatic cancer	0.000465	0.0082	CcSEcCtD
Pasireotide—Influenza—Tamoxifen—pancreatic cancer	0.000461	0.00812	CcSEcCtD
Pasireotide—Pain in extremity—Sunitinib—pancreatic cancer	0.000457	0.00805	CcSEcCtD
Pasireotide—Dry skin—Sunitinib—pancreatic cancer	0.000419	0.00737	CcSEcCtD
Pasireotide—Abdominal pain upper—Sunitinib—pancreatic cancer	0.000417	0.00735	CcSEcCtD
Pasireotide—Hypokalaemia—Sunitinib—pancreatic cancer	0.000416	0.00732	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Sunitinib—pancreatic cancer	0.000411	0.00724	CcSEcCtD
Pasireotide—Nasopharyngitis—Sunitinib—pancreatic cancer	0.000408	0.00719	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Sunitinib—pancreatic cancer	0.000403	0.0071	CcSEcCtD
Pasireotide—Abdominal distension—Sunitinib—pancreatic cancer	0.000397	0.007	CcSEcCtD
Pasireotide—Oedema peripheral—Tamoxifen—pancreatic cancer	0.000363	0.0064	CcSEcCtD
Pasireotide—Injection site reaction—Docetaxel—pancreatic cancer	0.000356	0.00627	CcSEcCtD
Pasireotide—Hyperglycaemia—Sunitinib—pancreatic cancer	0.000356	0.00627	CcSEcCtD
Pasireotide—Hypokalaemia—Irinotecan—pancreatic cancer	0.000342	0.00603	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Irinotecan—pancreatic cancer	0.000339	0.00597	CcSEcCtD
Pasireotide—Hypokalaemia—Gemcitabine—pancreatic cancer	0.000333	0.00588	CcSEcCtD
Pasireotide—Dry skin—Fluorouracil—pancreatic cancer	0.00033	0.00582	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.00033	0.00581	CcSEcCtD
Pasireotide—Abdominal distension—Irinotecan—pancreatic cancer	0.000327	0.00577	CcSEcCtD
Pasireotide—Alopecia—Tamoxifen—pancreatic cancer	0.000326	0.00574	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000323	0.00569	CcSEcCtD
Pasireotide—Alopecia—Erlotinib—pancreatic cancer	0.000322	0.00568	CcSEcCtD
Pasireotide—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.000322	0.00568	CcSEcCtD
Pasireotide—Influenza—Gemcitabine—pancreatic cancer	0.000317	0.00558	CcSEcCtD
Pasireotide—Oedema peripheral—Sunitinib—pancreatic cancer	0.000311	0.00548	CcSEcCtD
Pasireotide—Back pain—Tamoxifen—pancreatic cancer	0.000311	0.00547	CcSEcCtD
Pasireotide—Back pain—Erlotinib—pancreatic cancer	0.000307	0.00541	CcSEcCtD
Pasireotide—Anaemia—Tamoxifen—pancreatic cancer	0.000297	0.00523	CcSEcCtD
Pasireotide—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000286	0.00503	CcSEcCtD
Pasireotide—Alopecia—Sunitinib—pancreatic cancer	0.000279	0.00492	CcSEcCtD
Pasireotide—Hypertension—Tamoxifen—pancreatic cancer	0.000277	0.00488	CcSEcCtD
Pasireotide—Myalgia—Tamoxifen—pancreatic cancer	0.000273	0.00482	CcSEcCtD
Pasireotide—Arthralgia—Tamoxifen—pancreatic cancer	0.000273	0.00482	CcSEcCtD
Pasireotide—Anxiety—Tamoxifen—pancreatic cancer	0.000272	0.0048	CcSEcCtD
Pasireotide—Arthralgia—Erlotinib—pancreatic cancer	0.00027	0.00476	CcSEcCtD
Pasireotide—Myalgia—Erlotinib—pancreatic cancer	0.00027	0.00476	CcSEcCtD
Pasireotide—Anxiety—Erlotinib—pancreatic cancer	0.00027	0.00475	CcSEcCtD
Pasireotide—Back pain—Sunitinib—pancreatic cancer	0.000266	0.00469	CcSEcCtD
Pasireotide—Pain in extremity—Docetaxel—pancreatic cancer	0.00026	0.00458	CcSEcCtD
Pasireotide—Anaemia—Sunitinib—pancreatic cancer	0.000254	0.00448	CcSEcCtD
Pasireotide—Oedema peripheral—Gemcitabine—pancreatic cancer	0.00025	0.0044	CcSEcCtD
Pasireotide—Injection site reaction—Epirubicin—pancreatic cancer	0.00024	0.00423	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000239	0.00421	CcSEcCtD
Pasireotide—Dry skin—Docetaxel—pancreatic cancer	0.000238	0.0042	CcSEcCtD
Pasireotide—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000237	0.00418	CcSEcCtD
Pasireotide—Hypertension—Sunitinib—pancreatic cancer	0.000237	0.00418	CcSEcCtD
Pasireotide—Insomnia—Tamoxifen—pancreatic cancer	0.000237	0.00418	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000236	0.00416	CcSEcCtD
Pasireotide—Insomnia—Erlotinib—pancreatic cancer	0.000234	0.00413	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000234	0.00413	CcSEcCtD
Pasireotide—Myalgia—Sunitinib—pancreatic cancer	0.000234	0.00412	CcSEcCtD
Pasireotide—Arthralgia—Sunitinib—pancreatic cancer	0.000234	0.00412	CcSEcCtD
Pasireotide—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000233	0.0041	CcSEcCtD
Pasireotide—Alopecia—Irinotecan—pancreatic cancer	0.00023	0.00405	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000229	0.00404	CcSEcCtD
Pasireotide—Decreased appetite—Tamoxifen—pancreatic cancer	0.000228	0.00401	CcSEcCtD
Pasireotide—Fatigue—Tamoxifen—pancreatic cancer	0.000226	0.00398	CcSEcCtD
Pasireotide—Decreased appetite—Erlotinib—pancreatic cancer	0.000225	0.00397	CcSEcCtD
Pasireotide—Constipation—Tamoxifen—pancreatic cancer	0.000224	0.00395	CcSEcCtD
Pasireotide—Alopecia—Gemcitabine—pancreatic cancer	0.000224	0.00395	CcSEcCtD
Pasireotide—Fatigue—Erlotinib—pancreatic cancer	0.000224	0.00394	CcSEcCtD
Pasireotide—Injection site reaction—Doxorubicin—pancreatic cancer	0.000222	0.00392	CcSEcCtD
Pasireotide—Constipation—Erlotinib—pancreatic cancer	0.000222	0.00391	CcSEcCtD
Pasireotide—Alopecia—Fluorouracil—pancreatic cancer	0.00022	0.00388	CcSEcCtD
Pasireotide—Back pain—Irinotecan—pancreatic cancer	0.000219	0.00386	CcSEcCtD
Pasireotide—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000214	0.00378	CcSEcCtD
Pasireotide—Back pain—Gemcitabine—pancreatic cancer	0.000213	0.00376	CcSEcCtD
Pasireotide—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000212	0.00374	CcSEcCtD
Pasireotide—Anaemia—Irinotecan—pancreatic cancer	0.000209	0.00369	CcSEcCtD
Pasireotide—Abdominal pain—Tamoxifen—pancreatic cancer	0.000207	0.00365	CcSEcCtD
Pasireotide—Abdominal pain—Erlotinib—pancreatic cancer	0.000205	0.00361	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000204	0.0036	CcSEcCtD
Pasireotide—Anaemia—Gemcitabine—pancreatic cancer	0.000204	0.00359	CcSEcCtD
Pasireotide—Vertigo—Irinotecan—pancreatic cancer	0.000204	0.00359	CcSEcCtD
Pasireotide—Insomnia—Sunitinib—pancreatic cancer	0.000203	0.00358	CcSEcCtD
Pasireotide—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000202	0.00355	CcSEcCtD
Pasireotide—Anaemia—Fluorouracil—pancreatic cancer	0.000201	0.00353	CcSEcCtD
Pasireotide—Hypertension—Irinotecan—pancreatic cancer	0.000196	0.00345	CcSEcCtD
Pasireotide—Decreased appetite—Sunitinib—pancreatic cancer	0.000195	0.00344	CcSEcCtD
Pasireotide—Fatigue—Sunitinib—pancreatic cancer	0.000194	0.00341	CcSEcCtD
Pasireotide—Constipation—Sunitinib—pancreatic cancer	0.000192	0.00338	CcSEcCtD
Pasireotide—Hypertension—Gemcitabine—pancreatic cancer	0.000191	0.00336	CcSEcCtD
Pasireotide—Asthenia—Tamoxifen—pancreatic cancer	0.000188	0.00331	CcSEcCtD
Pasireotide—Arthralgia—Gemcitabine—pancreatic cancer	0.000188	0.00331	CcSEcCtD
Pasireotide—Myalgia—Gemcitabine—pancreatic cancer	0.000188	0.00331	CcSEcCtD
Pasireotide—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000187	0.00329	CcSEcCtD
Pasireotide—Asthenia—Erlotinib—pancreatic cancer	0.000186	0.00328	CcSEcCtD
Pasireotide—Pruritus—Tamoxifen—pancreatic cancer	0.000185	0.00327	CcSEcCtD
Pasireotide—Myalgia—Fluorouracil—pancreatic cancer	0.000185	0.00325	CcSEcCtD
Pasireotide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000184	0.00323	CcSEcCtD
Pasireotide—Pruritus—Erlotinib—pancreatic cancer	0.000183	0.00323	CcSEcCtD
Pasireotide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00018	0.00317	CcSEcCtD
Pasireotide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000179	0.00316	CcSEcCtD
Pasireotide—Abdominal pain—Sunitinib—pancreatic cancer	0.000177	0.00313	CcSEcCtD
Pasireotide—Diarrhoea—Erlotinib—pancreatic cancer	0.000177	0.00313	CcSEcCtD
Pasireotide—Oedema peripheral—Docetaxel—pancreatic cancer	0.000177	0.00312	CcSEcCtD
Pasireotide—Pain in extremity—Epirubicin—pancreatic cancer	0.000175	0.00309	CcSEcCtD
Pasireotide—Dizziness—Tamoxifen—pancreatic cancer	0.000173	0.00305	CcSEcCtD
Pasireotide—Hypotension—Irinotecan—pancreatic cancer	0.000173	0.00304	CcSEcCtD
Pasireotide—Dizziness—Erlotinib—pancreatic cancer	0.000171	0.00302	CcSEcCtD
Pasireotide—Hypotension—Gemcitabine—pancreatic cancer	0.000168	0.00296	CcSEcCtD
Pasireotide—Insomnia—Irinotecan—pancreatic cancer	0.000167	0.00295	CcSEcCtD
Pasireotide—Vomiting—Tamoxifen—pancreatic cancer	0.000167	0.00294	CcSEcCtD
Pasireotide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000166	0.00293	CcSEcCtD
Pasireotide—Hypotension—Fluorouracil—pancreatic cancer	0.000165	0.00292	CcSEcCtD
Pasireotide—Vomiting—Erlotinib—pancreatic cancer	0.000165	0.0029	CcSEcCtD
Pasireotide—Headache—Tamoxifen—pancreatic cancer	0.000164	0.00289	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000164	0.00289	CcSEcCtD
Pasireotide—Insomnia—Gemcitabine—pancreatic cancer	0.000163	0.00287	CcSEcCtD
Pasireotide—Headache—Erlotinib—pancreatic cancer	0.000162	0.00286	CcSEcCtD
Pasireotide—Pain in extremity—Doxorubicin—pancreatic cancer	0.000162	0.00286	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000161	0.00284	CcSEcCtD
Pasireotide—Asthenia—Sunitinib—pancreatic cancer	0.000161	0.00284	CcSEcCtD
Pasireotide—Dry skin—Epirubicin—pancreatic cancer	0.000161	0.00283	CcSEcCtD
Pasireotide—Decreased appetite—Irinotecan—pancreatic cancer	0.000161	0.00283	CcSEcCtD
Pasireotide—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00016	0.00282	CcSEcCtD
Pasireotide—Insomnia—Fluorouracil—pancreatic cancer	0.00016	0.00282	CcSEcCtD
Pasireotide—Hypokalaemia—Epirubicin—pancreatic cancer	0.00016	0.00281	CcSEcCtD
Pasireotide—Fatigue—Irinotecan—pancreatic cancer	0.000159	0.00281	CcSEcCtD
Pasireotide—Alopecia—Docetaxel—pancreatic cancer	0.000159	0.0028	CcSEcCtD
Pasireotide—Pruritus—Sunitinib—pancreatic cancer	0.000159	0.0028	CcSEcCtD
Pasireotide—Constipation—Irinotecan—pancreatic cancer	0.000158	0.00279	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000158	0.00278	CcSEcCtD
Pasireotide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000157	0.00276	CcSEcCtD
Pasireotide—Decreased appetite—Gemcitabine—pancreatic cancer	0.000157	0.00276	CcSEcCtD
Pasireotide—Nausea—Tamoxifen—pancreatic cancer	0.000156	0.00274	CcSEcCtD
Pasireotide—Fatigue—Gemcitabine—pancreatic cancer	0.000155	0.00274	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000155	0.00273	CcSEcCtD
Pasireotide—Constipation—Gemcitabine—pancreatic cancer	0.000154	0.00271	CcSEcCtD
Pasireotide—Nausea—Erlotinib—pancreatic cancer	0.000154	0.00271	CcSEcCtD
Pasireotide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000154	0.00271	CcSEcCtD
Pasireotide—Diarrhoea—Sunitinib—pancreatic cancer	0.000154	0.00271	CcSEcCtD
Pasireotide—Abdominal distension—Epirubicin—pancreatic cancer	0.000153	0.00269	CcSEcCtD
Pasireotide—Influenza—Epirubicin—pancreatic cancer	0.000152	0.00267	CcSEcCtD
Pasireotide—Back pain—Docetaxel—pancreatic cancer	0.000151	0.00267	CcSEcCtD
Pasireotide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000151	0.00266	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—pancreatic cancer	0.000149	0.00262	CcSEcCtD
Pasireotide—Dizziness—Sunitinib—pancreatic cancer	0.000148	0.00261	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000148	0.00261	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000148	0.0026	CcSEcCtD
Pasireotide—Abdominal pain—Irinotecan—pancreatic cancer	0.000146	0.00257	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000146	0.00257	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000145	0.00256	CcSEcCtD
Pasireotide—Anaemia—Docetaxel—pancreatic cancer	0.000145	0.00255	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000143	0.00252	CcSEcCtD
Pasireotide—Vomiting—Sunitinib—pancreatic cancer	0.000143	0.00251	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—pancreatic cancer	0.000141	0.00249	CcSEcCtD
Pasireotide—Headache—Sunitinib—pancreatic cancer	0.000141	0.00248	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—pancreatic cancer	0.00014	0.00247	CcSEcCtD
Pasireotide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000137	0.00241	CcSEcCtD
Pasireotide—Hypertension—Docetaxel—pancreatic cancer	0.000135	0.00238	CcSEcCtD
Pasireotide—Arthralgia—Docetaxel—pancreatic cancer	0.000133	0.00235	CcSEcCtD
Pasireotide—Myalgia—Docetaxel—pancreatic cancer	0.000133	0.00235	CcSEcCtD
Pasireotide—Nausea—Sunitinib—pancreatic cancer	0.000133	0.00235	CcSEcCtD
Pasireotide—Asthenia—Irinotecan—pancreatic cancer	0.000133	0.00234	CcSEcCtD
Pasireotide—Asthenia—Gemcitabine—pancreatic cancer	0.000129	0.00228	CcSEcCtD
Pasireotide—Pruritus—Gemcitabine—pancreatic cancer	0.000127	0.00224	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000127	0.00223	CcSEcCtD
Pasireotide—Diarrhoea—Irinotecan—pancreatic cancer	0.000126	0.00223	CcSEcCtD
Pasireotide—Pruritus—Fluorouracil—pancreatic cancer	0.000125	0.00221	CcSEcCtD
Pasireotide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000123	0.00217	CcSEcCtD
Pasireotide—Dizziness—Irinotecan—pancreatic cancer	0.000122	0.00215	CcSEcCtD
Pasireotide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000121	0.00213	CcSEcCtD
Pasireotide—Oedema peripheral—Epirubicin—pancreatic cancer	0.00012	0.00211	CcSEcCtD
Pasireotide—Hypotension—Docetaxel—pancreatic cancer	0.000119	0.0021	CcSEcCtD
Pasireotide—Vomiting—Irinotecan—pancreatic cancer	0.000118	0.00207	CcSEcCtD
Pasireotide—Dizziness—Fluorouracil—pancreatic cancer	0.000117	0.00206	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000116	0.00205	CcSEcCtD
Pasireotide—Headache—Irinotecan—pancreatic cancer	0.000116	0.00204	CcSEcCtD
Pasireotide—Insomnia—Docetaxel—pancreatic cancer	0.000116	0.00204	CcSEcCtD
Pasireotide—Vomiting—Gemcitabine—pancreatic cancer	0.000115	0.00202	CcSEcCtD
Pasireotide—Headache—Gemcitabine—pancreatic cancer	0.000113	0.00199	CcSEcCtD
Pasireotide—Vomiting—Fluorouracil—pancreatic cancer	0.000113	0.00198	CcSEcCtD
Pasireotide—Decreased appetite—Docetaxel—pancreatic cancer	0.000111	0.00196	CcSEcCtD
Pasireotide—Headache—Fluorouracil—pancreatic cancer	0.000111	0.00195	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000111	0.00195	CcSEcCtD
Pasireotide—Fatigue—Docetaxel—pancreatic cancer	0.00011	0.00194	CcSEcCtD
Pasireotide—Nausea—Irinotecan—pancreatic cancer	0.00011	0.00193	CcSEcCtD
Pasireotide—Constipation—Docetaxel—pancreatic cancer	0.000109	0.00193	CcSEcCtD
Pasireotide—Alopecia—Epirubicin—pancreatic cancer	0.000107	0.00189	CcSEcCtD
Pasireotide—Nausea—Gemcitabine—pancreatic cancer	0.000107	0.00188	CcSEcCtD
Pasireotide—Nausea—Fluorouracil—pancreatic cancer	0.000105	0.00185	CcSEcCtD
Pasireotide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000105	0.00184	CcSEcCtD
Pasireotide—Back pain—Epirubicin—pancreatic cancer	0.000102	0.0018	CcSEcCtD
Pasireotide—Abdominal pain—Docetaxel—pancreatic cancer	0.000101	0.00178	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—pancreatic cancer	9.92e-05	0.00175	CcSEcCtD
Pasireotide—Anaemia—Epirubicin—pancreatic cancer	9.76e-05	0.00172	CcSEcCtD
Pasireotide—Desmopressin—PTGS2—pancreatic cancer	9.75e-05	0.017	CrCbGaD
Pasireotide—Vertigo—Epirubicin—pancreatic cancer	9.49e-05	0.00167	CcSEcCtD
Pasireotide—Back pain—Doxorubicin—pancreatic cancer	9.45e-05	0.00167	CcSEcCtD
Pasireotide—Asthenia—Docetaxel—pancreatic cancer	9.17e-05	0.00162	CcSEcCtD
Pasireotide—Hypertension—Epirubicin—pancreatic cancer	9.12e-05	0.00161	CcSEcCtD
Pasireotide—Pruritus—Docetaxel—pancreatic cancer	9.04e-05	0.00159	CcSEcCtD
Pasireotide—Anaemia—Doxorubicin—pancreatic cancer	9.03e-05	0.00159	CcSEcCtD
Pasireotide—Arthralgia—Epirubicin—pancreatic cancer	8.99e-05	0.00158	CcSEcCtD
Pasireotide—Myalgia—Epirubicin—pancreatic cancer	8.99e-05	0.00158	CcSEcCtD
Pasireotide—Anxiety—Epirubicin—pancreatic cancer	8.96e-05	0.00158	CcSEcCtD
Pasireotide—Vertigo—Doxorubicin—pancreatic cancer	8.78e-05	0.00155	CcSEcCtD
Pasireotide—Diarrhoea—Docetaxel—pancreatic cancer	8.74e-05	0.00154	CcSEcCtD
Pasireotide—Dizziness—Docetaxel—pancreatic cancer	8.45e-05	0.00149	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—pancreatic cancer	8.44e-05	0.00149	CcSEcCtD
Pasireotide—Arthralgia—Doxorubicin—pancreatic cancer	8.32e-05	0.00147	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—pancreatic cancer	8.32e-05	0.00147	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—pancreatic cancer	8.29e-05	0.00146	CcSEcCtD
Pasireotide—Vomiting—Docetaxel—pancreatic cancer	8.13e-05	0.00143	CcSEcCtD
Pasireotide—Hypotension—Epirubicin—pancreatic cancer	8.05e-05	0.00142	CcSEcCtD
Pasireotide—Headache—Docetaxel—pancreatic cancer	8.01e-05	0.00141	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.85e-05	0.00138	CcSEcCtD
Pasireotide—Insomnia—Epirubicin—pancreatic cancer	7.8e-05	0.00137	CcSEcCtD
Pasireotide—Nausea—Docetaxel—pancreatic cancer	7.59e-05	0.00134	CcSEcCtD
Pasireotide—Decreased appetite—Epirubicin—pancreatic cancer	7.49e-05	0.00132	CcSEcCtD
Pasireotide—Hypotension—Doxorubicin—pancreatic cancer	7.45e-05	0.00131	CcSEcCtD
Pasireotide—Fatigue—Epirubicin—pancreatic cancer	7.43e-05	0.00131	CcSEcCtD
Pasireotide—Constipation—Epirubicin—pancreatic cancer	7.37e-05	0.0013	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.27e-05	0.00128	CcSEcCtD
Pasireotide—Insomnia—Doxorubicin—pancreatic cancer	7.21e-05	0.00127	CcSEcCtD
Pasireotide—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.05e-05	0.00124	CcSEcCtD
Pasireotide—Decreased appetite—Doxorubicin—pancreatic cancer	6.93e-05	0.00122	CcSEcCtD
Pasireotide—Fatigue—Doxorubicin—pancreatic cancer	6.88e-05	0.00121	CcSEcCtD
Pasireotide—Constipation—Doxorubicin—pancreatic cancer	6.82e-05	0.0012	CcSEcCtD
Pasireotide—Abdominal pain—Epirubicin—pancreatic cancer	6.81e-05	0.0012	CcSEcCtD
Pasireotide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.52e-05	0.00115	CcSEcCtD
Pasireotide—Abdominal pain—Doxorubicin—pancreatic cancer	6.31e-05	0.00111	CcSEcCtD
Pasireotide—Asthenia—Epirubicin—pancreatic cancer	6.18e-05	0.00109	CcSEcCtD
Pasireotide—Pruritus—Epirubicin—pancreatic cancer	6.1e-05	0.00107	CcSEcCtD
Pasireotide—Diarrhoea—Epirubicin—pancreatic cancer	5.9e-05	0.00104	CcSEcCtD
Pasireotide—Asthenia—Doxorubicin—pancreatic cancer	5.72e-05	0.00101	CcSEcCtD
Pasireotide—Dizziness—Epirubicin—pancreatic cancer	5.7e-05	0.001	CcSEcCtD
Pasireotide—Pruritus—Doxorubicin—pancreatic cancer	5.64e-05	0.000994	CcSEcCtD
Pasireotide—Vomiting—Epirubicin—pancreatic cancer	5.48e-05	0.000966	CcSEcCtD
Pasireotide—Diarrhoea—Doxorubicin—pancreatic cancer	5.46e-05	0.000961	CcSEcCtD
Pasireotide—Headache—Epirubicin—pancreatic cancer	5.4e-05	0.000951	CcSEcCtD
Pasireotide—Dizziness—Doxorubicin—pancreatic cancer	5.27e-05	0.000929	CcSEcCtD
Pasireotide—Nausea—Epirubicin—pancreatic cancer	5.12e-05	0.000902	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—AGTR1—pancreatic cancer	5.08e-05	0.000472	CbGpPWpGaD
Pasireotide—Vomiting—Doxorubicin—pancreatic cancer	5.07e-05	0.000893	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—CCK—pancreatic cancer	5.05e-05	0.000469	CbGpPWpGaD
Pasireotide—Headache—Doxorubicin—pancreatic cancer	5e-05	0.00088	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—SHH—pancreatic cancer	4.98e-05	0.000462	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOTCH4—pancreatic cancer	4.95e-05	0.000459	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTCH1—pancreatic cancer	4.92e-05	0.000457	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTHLH—pancreatic cancer	4.92e-05	0.000457	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CNR2—pancreatic cancer	4.92e-05	0.000457	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GLP1R—pancreatic cancer	4.92e-05	0.000457	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCL8—pancreatic cancer	4.92e-05	0.000456	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IAPP—pancreatic cancer	4.91e-05	0.000456	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SCT—pancreatic cancer	4.88e-05	0.000453	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HEY1—pancreatic cancer	4.88e-05	0.000453	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCKAR—pancreatic cancer	4.84e-05	0.000449	CbGpPWpGaD
Pasireotide—Nausea—Doxorubicin—pancreatic cancer	4.74e-05	0.000835	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—PTHLH—pancreatic cancer	4.72e-05	0.000438	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTCH1—pancreatic cancer	4.72e-05	0.000438	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JAG2—pancreatic cancer	4.69e-05	0.000436	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCK—pancreatic cancer	4.66e-05	0.000432	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MEN1—pancreatic cancer	4.63e-05	0.000429	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CNR2—pancreatic cancer	4.54e-05	0.000421	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GLP1R—pancreatic cancer	4.54e-05	0.000421	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCL8—pancreatic cancer	4.54e-05	0.000421	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SST—pancreatic cancer	4.5e-05	0.000418	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCKAR—pancreatic cancer	4.47e-05	0.000415	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.44e-05	0.000412	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SHH—pancreatic cancer	4.41e-05	0.00041	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JAG1—pancreatic cancer	4.4e-05	0.000409	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOTCH3—pancreatic cancer	4.39e-05	0.000407	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOTCH4—pancreatic cancer	4.39e-05	0.000407	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IAPP—pancreatic cancer	4.36e-05	0.000404	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JAG2—pancreatic cancer	4.33e-05	0.000402	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SST—pancreatic cancer	4.31e-05	0.0004	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MEN1—pancreatic cancer	4.27e-05	0.000396	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.26e-05	0.000395	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JAG1—pancreatic cancer	4.22e-05	0.000392	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOTCH3—pancreatic cancer	4.2e-05	0.00039	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTHLH—pancreatic cancer	4.18e-05	0.000388	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTCH1—pancreatic cancer	4.18e-05	0.000388	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CNR1—pancreatic cancer	4.15e-05	0.000385	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SHH—pancreatic cancer	4.07e-05	0.000378	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOTCH4—pancreatic cancer	4.05e-05	0.000376	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CG—pancreatic cancer	4.03e-05	0.000374	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IAPP—pancreatic cancer	4.02e-05	0.000373	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GCG—pancreatic cancer	4.01e-05	0.000372	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CNR1—pancreatic cancer	3.98e-05	0.000369	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.9e-05	0.000362	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.86e-05	0.000359	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTCH1—pancreatic cancer	3.86e-05	0.000358	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTHLH—pancreatic cancer	3.86e-05	0.000358	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GCG—pancreatic cancer	3.85e-05	0.000357	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AGTR1—pancreatic cancer	3.83e-05	0.000355	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SST—pancreatic cancer	3.83e-05	0.000355	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.77e-05	0.00035	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STK11—pancreatic cancer	3.77e-05	0.00035	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JAG1—pancreatic cancer	3.74e-05	0.000347	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.74e-05	0.000347	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOTCH3—pancreatic cancer	3.73e-05	0.000346	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AGTR1—pancreatic cancer	3.67e-05	0.00034	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STK11—pancreatic cancer	3.62e-05	0.000336	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CD—pancreatic cancer	3.54e-05	0.000329	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SST—pancreatic cancer	3.53e-05	0.000328	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CNR1—pancreatic cancer	3.53e-05	0.000328	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.48e-05	0.000323	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JAG1—pancreatic cancer	3.46e-05	0.000321	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOTCH3—pancreatic cancer	3.44e-05	0.000319	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CG—pancreatic cancer	3.43e-05	0.000318	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GCG—pancreatic cancer	3.41e-05	0.000316	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.4e-05	0.000316	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.4e-05	0.000315	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.32e-05	0.000308	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SMAD4—pancreatic cancer	3.3e-05	0.000307	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL8—pancreatic cancer	3.27e-05	0.000303	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.26e-05	0.000303	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CNR1—pancreatic cancer	3.26e-05	0.000302	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AGTR1—pancreatic cancer	3.25e-05	0.000302	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HES1—pancreatic cancer	3.23e-05	0.000299	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STK11—pancreatic cancer	3.21e-05	0.000298	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SMAD4—pancreatic cancer	3.17e-05	0.000294	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CG—pancreatic cancer	3.16e-05	0.000293	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GCG—pancreatic cancer	3.15e-05	0.000292	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL8—pancreatic cancer	3.13e-05	0.000291	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HES1—pancreatic cancer	3.09e-05	0.000287	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CB—pancreatic cancer	3.09e-05	0.000287	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.06e-05	0.000284	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CD—pancreatic cancer	3.01e-05	0.00028	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AGTR1—pancreatic cancer	3e-05	0.000279	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL8—pancreatic cancer	2.97e-05	0.000275	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.96e-05	0.000275	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STK11—pancreatic cancer	2.96e-05	0.000275	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.89e-05	0.000268	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL8—pancreatic cancer	2.85e-05	0.000264	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TERT—pancreatic cancer	2.83e-05	0.000262	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SMAD4—pancreatic cancer	2.81e-05	0.000261	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.78e-05	0.000258	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL8—pancreatic cancer	2.78e-05	0.000258	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HES1—pancreatic cancer	2.74e-05	0.000254	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TERT—pancreatic cancer	2.71e-05	0.000251	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HIF1A—pancreatic cancer	2.7e-05	0.000251	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSC2—pancreatic cancer	2.7e-05	0.00025	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.67e-05	0.000248	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOE—pancreatic cancer	2.64e-05	0.000245	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CB—pancreatic cancer	2.63e-05	0.000244	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SMAD4—pancreatic cancer	2.59e-05	0.000241	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HIF1A—pancreatic cancer	2.59e-05	0.00024	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KDR—pancreatic cancer	2.58e-05	0.00024	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSC2—pancreatic cancer	2.58e-05	0.00024	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.56e-05	0.000238	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HES1—pancreatic cancer	2.53e-05	0.000235	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOE—pancreatic cancer	2.53e-05	0.000235	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL8—pancreatic cancer	2.52e-05	0.000234	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KDR—pancreatic cancer	2.48e-05	0.00023	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NFKBIA—pancreatic cancer	2.46e-05	0.000228	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOTCH1—pancreatic cancer	2.43e-05	0.000226	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.42e-05	0.000225	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TERT—pancreatic cancer	2.4e-05	0.000223	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—pancreatic cancer	2.38e-05	0.000221	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—NRAS—pancreatic cancer	2.38e-05	0.000221	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NFKBIA—pancreatic cancer	2.36e-05	0.000219	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGF—pancreatic cancer	2.35e-05	0.000218	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOTCH1—pancreatic cancer	2.33e-05	0.000217	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL8—pancreatic cancer	2.33e-05	0.000216	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HIF1A—pancreatic cancer	2.3e-05	0.000213	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSC2—pancreatic cancer	2.29e-05	0.000213	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—pancreatic cancer	2.28e-05	0.000212	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—NRAS—pancreatic cancer	2.28e-05	0.000212	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGF—pancreatic cancer	2.26e-05	0.000209	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOE—pancreatic cancer	2.24e-05	0.000208	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TERT—pancreatic cancer	2.22e-05	0.000206	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KDR—pancreatic cancer	2.2e-05	0.000204	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—pancreatic cancer	2.17e-05	0.000201	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HIF1A—pancreatic cancer	2.12e-05	0.000197	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSC2—pancreatic cancer	2.12e-05	0.000196	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CD—pancreatic cancer	2.09e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NFKBIA—pancreatic cancer	2.09e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—pancreatic cancer	2.08e-05	0.000193	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.07e-05	0.000192	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOTCH1—pancreatic cancer	2.07e-05	0.000192	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOE—pancreatic cancer	2.07e-05	0.000192	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—KRAS—pancreatic cancer	2.05e-05	0.00019	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KDR—pancreatic cancer	2.03e-05	0.000188	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—pancreatic cancer	2.02e-05	0.000188	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—NRAS—pancreatic cancer	2.02e-05	0.000188	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CD—pancreatic cancer	2.01e-05	0.000186	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGF—pancreatic cancer	2e-05	0.000186	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.99e-05	0.000184	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—KRAS—pancreatic cancer	1.96e-05	0.000182	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NFKBIA—pancreatic cancer	1.93e-05	0.000179	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOTCH1—pancreatic cancer	1.91e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.88e-05	0.000175	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—pancreatic cancer	1.87e-05	0.000173	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—NRAS—pancreatic cancer	1.87e-05	0.000173	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGF—pancreatic cancer	1.85e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—pancreatic cancer	1.84e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CB—pancreatic cancer	1.82e-05	0.000169	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.81e-05	0.000168	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CD—pancreatic cancer	1.78e-05	0.000165	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.76e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL8—pancreatic cancer	1.75e-05	0.000163	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.75e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—KRAS—pancreatic cancer	1.74e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HRAS—pancreatic cancer	1.74e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—pancreatic cancer	1.7e-05	0.000158	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—pancreatic cancer	1.69e-05	0.000157	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL8—pancreatic cancer	1.68e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP3—pancreatic cancer	1.68e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HRAS—pancreatic cancer	1.67e-05	0.000155	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CD—pancreatic cancer	1.64e-05	0.000152	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—pancreatic cancer	1.63e-05	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.63e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—pancreatic cancer	1.62e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNB1—pancreatic cancer	1.62e-05	0.00015	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP3—pancreatic cancer	1.61e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—KRAS—pancreatic cancer	1.61e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—pancreatic cancer	1.6e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—pancreatic cancer	1.59e-05	0.000147	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTEN—pancreatic cancer	1.58e-05	0.000146	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—pancreatic cancer	1.57e-05	0.000145	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CB—pancreatic cancer	1.55e-05	0.000144	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.55e-05	0.000144	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—pancreatic cancer	1.54e-05	0.000143	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—pancreatic cancer	1.52e-05	0.000141	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTEN—pancreatic cancer	1.51e-05	0.00014	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL8—pancreatic cancer	1.49e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HRAS—pancreatic cancer	1.48e-05	0.000137	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.48e-05	0.000137	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—pancreatic cancer	1.47e-05	0.000137	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SRC—pancreatic cancer	1.46e-05	0.000136	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—pancreatic cancer	1.44e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CB—pancreatic cancer	1.43e-05	0.000133	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP3—pancreatic cancer	1.43e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—pancreatic cancer	1.42e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—pancreatic cancer	1.41e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NRAS—pancreatic cancer	1.41e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SRC—pancreatic cancer	1.4e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—pancreatic cancer	1.39e-05	0.000129	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL8—pancreatic cancer	1.38e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNB1—pancreatic cancer	1.38e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HRAS—pancreatic cancer	1.37e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—pancreatic cancer	1.37e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—pancreatic cancer	1.35e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NRAS—pancreatic cancer	1.35e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—pancreatic cancer	1.35e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTEN—pancreatic cancer	1.34e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—pancreatic cancer	1.33e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CASP3—pancreatic cancer	1.32e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—pancreatic cancer	1.31e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—pancreatic cancer	1.31e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—pancreatic cancer	1.31e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—pancreatic cancer	1.28e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—pancreatic cancer	1.28e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNB1—pancreatic cancer	1.27e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—pancreatic cancer	1.26e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—pancreatic cancer	1.25e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—pancreatic cancer	1.24e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SRC—pancreatic cancer	1.24e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTEN—pancreatic cancer	1.24e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—pancreatic cancer	1.23e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—pancreatic cancer	1.21e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KRAS—pancreatic cancer	1.21e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—pancreatic cancer	1.21e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—pancreatic cancer	1.2e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NRAS—pancreatic cancer	1.2e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KRAS—pancreatic cancer	1.16e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SRC—pancreatic cancer	1.15e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—pancreatic cancer	1.12e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—pancreatic cancer	1.11e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—pancreatic cancer	1.11e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—pancreatic cancer	1.11e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—pancreatic cancer	1.11e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NRAS—pancreatic cancer	1.1e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—pancreatic cancer	1.09e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—pancreatic cancer	1.08e-05	9.98e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.07e-05	9.89e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—pancreatic cancer	1.03e-05	9.57e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KRAS—pancreatic cancer	1.03e-05	9.55e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HRAS—pancreatic cancer	1.03e-05	9.55e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—pancreatic cancer	1.03e-05	9.54e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—pancreatic cancer	1.03e-05	9.52e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—pancreatic cancer	1.01e-05	9.33e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HRAS—pancreatic cancer	9.87e-06	9.15e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KRAS—pancreatic cancer	9.5e-06	8.82e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—pancreatic cancer	9.46e-06	8.78e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—pancreatic cancer	9.15e-06	8.49e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—pancreatic cancer	9.09e-06	8.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HRAS—pancreatic cancer	8.75e-06	8.12e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—pancreatic cancer	8.73e-06	8.1e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—pancreatic cancer	8.71e-06	8.08e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—pancreatic cancer	8.44e-06	7.83e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRAS—pancreatic cancer	8.07e-06	7.49e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—pancreatic cancer	7.73e-06	7.17e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—pancreatic cancer	7.13e-06	6.62e-05	CbGpPWpGaD
